Cancer Case Studies Flashcards
Chronic Myeloid leukaemia presentation
No clinical symptoms
good health
Splenomegaly (palpable)
CML cells of origin
Neutrophil
Eosinophil
Basophil (mast cell)
Platelets
CML incidence
1.5 in 100,000 per year
675 new diagnosis UK 2011
Tyrosine Kinase Inhibitors (TKIs) 1st generation
Imatinib
TKI 2nd generation
Nilotinib
Dasatinib
TKI 3rd generation
Ponatinib
Bosutinib
CML Treatment algorithm
1st or 2nd generation TKI
If no response, 2nd generation TKI
Then allogeneic stem cell transplant
Hodgkins Classification
It is a Lymphoid neoplasm
Hodgkin Lymphoma
Non-Hodgkins Lymphoma (B Cell or T Cell)
B Cell non Hodgkins Lymphoma
Aggressive or Indolent
Aggressive- rapid, treat with chemo
Indolent- slow, watch and wait, patient asymptomatic
Chemoimmunotherapy- used against Lymphoid neoplasms
Cytostatic drugs + targeted immunotherapy (Rituximab)
Thalidomide
Lenalidomide
Anti-proliferative
Co-stimulation of T cells + NK cell activation
Anti-angiogenic
Bortezomib
Proteasome inhibitor
Temsirolimus
mTOR inhibitor